SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)
|
PureCycle Technologies, Inc. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
74623V103 (CUSIP Number) |
Matthew Whitehead 3000 El Camino Real, Building 5, Suite 450 Palo Alto, CA, 94306 332-242-8518 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
06/20/2025 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
CUSIP No. | 74623V103 |
1 |
Name of reporting person
SYLEBRA CAPITAL LLC | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
34,077,574.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
18.98 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IA, HC |
SCHEDULE 13D
|
CUSIP No. | 74623V103 |
1 |
Name of reporting person
Sylebra Capital Ltd | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
HONG KONG
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
34,077,574.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
18.98 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IA, HC |
SCHEDULE 13D
|
CUSIP No. | 74623V103 |
1 |
Name of reporting person
Sylebra Capital Management, Ltd | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
CAYMAN ISLANDS
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
34,077,574.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
18.98 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IA, HC |
SCHEDULE 13D
|
CUSIP No. | 74623V103 |
1 |
Name of reporting person
Gibson Daniel Patrick | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
ANTIGUA AND BARBUDA
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
34,934,774.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
19.46 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
Item 1. | Security and Issuer | |
(a) | Title of Class of Securities:
Common Stock | |
(b) | Name of Issuer:
PureCycle Technologies, Inc. | |
(c) | Address of Issuer's Principal Executive Offices:
20 NORTH ORANGE AVE, SUITE 106, ORLANDO,
FLORIDA
, 32801. | |
Item 1 Comment:
This Amendment No. 3 on Schedule 13D/A (this "Amendment") amends the Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission on March 24, 2022, as amended from time to time (the "Schedule 13D"), relating to the shares of common stock, par value $0.001 per share ("Common Stock"), of PureCycle Technologies, Inc., a Delaware corporation (the "Issuer"), with a class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The principal executive offices of the Issuer are located at 4651 Salisbury Road, Suite 400, Jacksonville, Florida 32256. Except as specifically provided herein, this Amendment does not modify any of the information previously reported in the Schedule 13D. Unless otherwise indicated herein, capitalized terms used but not defined in this Amendment shall have the same meanings herein as are ascribed to such terms in the Schedule 13D. | ||
Item 2. | Identity and Background | |
(a) | Sylebra Capital LLC ("Sylebra US") hereby files this Amendment on behalf of the Reporting Persons pursuant to the Agreement with Respect to Schedule 13D (the Joint Filing Agreement) attached to this Statement as Exhibit 99.1.
Sylebra US and Sylebra Capital Limited ("Sylebra HK") are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. ("SCP MF"), Sylebra Capital Parc Master Fund ("PARC MF"), Sylebra Capital Menlo Master Fund ("MENLO MF") and other advisory clients. The term Affiliated Investment Entities refers to SCP MF, PARC MF, MENLO MF and the other advisory clients. Sylebra Capital Management ("Sylebra Cayman") is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK, and Daniel Patrick Gibson ("Gibson") owns 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra US, Sylebra Cayman, and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by the Affiliated Investment Entities. In addition, Gibson owns all of the outstanding equity interests in Gibsons Korner LLC ("GK LLC") and thus may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by GK LLC.
Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are each referred to herein individually as a Reporting Person and collectively as the Reporting Persons. | |
(b) | SYLEBRA CAPITAL LLC - 3000 El Camino Real, Building 5, Suite 450, Palo Alto, CA 94306
Sylebra Capital Ltd - 20th Floor, 256 Hennessy Road, Wan Chai, Hong Kong
Sylebra Capital Management, Ltd - c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town Grand Cayman KY1-9008, Cayman Islands
Gibson Daniel Patrick - 3000 El Camino Real, Building 5, Suite 450, Palo Alto, CA 94306 | |
(c) | SYLEBRA CAPITAL LLC - Investment Sub-Adviser
Sylebra Capital Ltd - Investment Sub-Adviser
Sylebra Capital Management, Ltd - Investment Manager
Gibson Daniel Patrick - (i) director and owner of Sylebra Capital Limited and Sylebra Capital Management and (ii) a sole member of Sylebra Capital LLC | |
(d) | SYLEBRA CAPITAL LLC - None
Sylebra Capital Ltd - None
Sylebra Capital Management, Ltd - None
Gibson Daniel Patrick - None | |
(e) | SYLEBRA CAPITAL LLC - None
Sylebra Capital Ltd - None
Sylebra Capital Management, Ltd - None
Gibson Daniel Patrick - None | |
(f) | SYLEBRA CAPITAL LLC - Delaware, US
Sylebra Capital Ltd - Hong Kong
Sylebra Capital Management, Ltd - Cayman Islands
Gibson Daniel Patrick - Antiqua and Barbuda | |
Item 3. | Source and Amount of Funds or Other Consideration | |
The Reporting Persons each used their respective working capital to purchase the shares of Common Stock of the Issuer. | ||
Item 4. | Purpose of Transaction | |
The purpose of the transactions was to acquire the securities of the Issuer for investment purposes with the aim of increasing the value of the investment and the Issuer.
On June 16, 2025, each of the Affiliated Investment Entities entered into subscription agreements (the "Subscription Agreements") with the Issuer, pursuant to which the Issuer agreed to sell to the Affiliated Investment Entities, in a private placement transaction, an aggregate of 40,000 shares of the Issuer's Series B Convertible Preferred Stock. The shares of Series B Convertible Preferred Stock are convertible into shares of the Issuer's Common Stock at a conversion rate equal to (a) the sum of $1,000 plus in kind dividends plus accrued dividends divided by (b) the conversion price, subject to a 19.99% ownership cap. The Series B Convertible Preferred Stock accrues cumulative dividends at a rate of 7% per annum, payable in kind or cash at the Issuer's option and has a liquidation preference equal to the greater of the accrued value of the Series B Convertible Preferred Stock at the time of the liquidation event or the amount receivable by the holders thereof if converted into the Issuer's Common stock. In the event of a change in control, holders of the Series B Convertible Preferred Stock may require the Issuer to redeem, or the Issuer may redeem, the Series B Convertible Preferred Stock for cash at the accrued value of the Series B Convertible Preferred Stock at the time of redemption. The Issuer has the right to convert the Series B Convertible Preferred Stock into Common Stock after the third anniversary of the closing date if certain trading price conditions are met. Pursuant to the Subscription Agreements, the Issuer is required to prepare and file a registration statement with the Securities and Exchange Commission under the Securities Act of 1933, as amended, covering the resale of the shares of the Issuer's Common Stock underlying the Series B Convertible Preferred Stock. The transactions subject to the Subscription Agreements closed on June 20, 2025.
Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to time in open market or private transactions, depending on their evaluation of the Issuers business, prospects and financial condition, the market for the Issuers securities, other developments concerning the Issuer, the reaction of the Issuer to the Reporting Persons ownership of the Issuers securities, other opportunities available to the Reporting Persons, and general economic, money market and stock market conditions. In addition, depending upon the factors referred to above, the Reporting Persons may dispose of all or a portion of their securities of the Issuer at any time. Each of the Reporting Persons reserves the right to increase or decrease its holdings on such terms and at such times as each may decide.
Other than as described above in this Item 4, none of the Reporting Persons have any plan or proposal relating to or that would result in: (a) the acquisition by any person of additional securities of the Issuer or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or terms of directors or to fill any existing vacancies on the Board of Directors of the Issuer; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuers business or corporate structure; (g) any changes in the Issuers charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) a class of securities of the Issuer being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (j) any action similar to those enumerated above. | ||
Item 5. | Interest in Securities of the Issuer | |
(a) | SYLEBRA CAPITAL LLC - 34,077,574; 18.98%
Sylebra Capital Ltd - 34,077,574; 18.98%
Sylebra Capital Management, Ltd - 34,077,574; 18.98%
Gibson Daniel Patrick - 34,934,774; 19.46% | |
(b) | SYLEBRA CAPITAL LLC - 34,077,574
Sylebra Capital Ltd - 34,077,574
Sylebra Capital Management, Ltd - 34,077,574
Gibson Daniel Patrick - Sole Voting / Dispositive Power: 714,300
Gibson Daniel Patrick - Shared Voting / Dispositive Power: 34,220,474 | |
(c) | Other than as disclosed above, there have been no reportable transactions with respect to the Issuer's Common Stock within the last 60 days by the Reporting Persons other than as described in this Statement . | |
(d) | No person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Issuer's Common Stock. | |
(e) | N/A | |
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
The information provided in Items 3, 4 and 5 is hereby incorporated herein by this reference.
Except for the Joint Filing Agreement attached hereto as Exhibit 99.1, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or, to the knowledge of any of the Reporting Persons, any other person or entity referred to in Item 2, or between such persons and any other person, with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finders fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. | ||
Item 7. | Material to be Filed as Exhibits. | |
Exhibit 99.1 Joint Filing Agreement, dated as of June 24, 2025, by and among the Reporting Persons. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|